Moreover, apart from apoptosis, cell cycle control, PI3K-AKT and NF-kB signaling pathways, other pathways and proteins should be further investigated as their possible potential targets of action against human cholangiocarcinoma. Here, NFKB1 is linked to cholangiocarcinoma.